PL428221A1 - Preparation accelerating wound healing process - Google Patents

Preparation accelerating wound healing process

Info

Publication number
PL428221A1
PL428221A1 PL428221A PL42822118A PL428221A1 PL 428221 A1 PL428221 A1 PL 428221A1 PL 428221 A PL428221 A PL 428221A PL 42822118 A PL42822118 A PL 42822118A PL 428221 A1 PL428221 A1 PL 428221A1
Authority
PL
Poland
Prior art keywords
healing process
wound healing
preparation
preparation accelerating
weight
Prior art date
Application number
PL428221A
Other languages
Polish (pl)
Other versions
PL242835B1 (en
Inventor
Mikołaj TOMULEWICZ
Original Assignee
Instytut Biotechnologii I Badań Medycznych Biolamed Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii I Badań Medycznych Biolamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Instytut Biotechnologii I Badań Medycznych Biolamed Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL428221A priority Critical patent/PL242835B1/en
Publication of PL428221A1 publication Critical patent/PL428221A1/en
Publication of PL242835B1 publication Critical patent/PL242835B1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest preparat przyspieszający proces gojenia się ran pochodzenia naturalnego stymulujący procesy naprawcze w tkankach. Preparat przyspieszający proces gojenia się ran zawiera jako substancję czynną ekstrakt wodny lub alkoholowy lub susz roślinny zawieszoną w podłożu organicznym charakteryzuje się tym, że zawiera w ilości od 1,0 do 20,0% wag. alkoholowego ekstraktu wodnego lub suszu z grzyba sromotnika smrodliwego (Phallus impudicus), a jako substancje aktywne zawiera PI-2 glucomannan. Preparat charakteryzuje się tym, że jako podłoże organiczne zawiera lanolinę w ilości od 40,0% do 49,5% wag. oraz wazelinę w ilości od 40,0% do 49,5% wag.The subject of the application is a preparation accelerating the healing process of wounds of natural origin, stimulating repair processes in tissues. The preparation accelerating the wound healing process contains as active ingredient an aqueous or alcoholic extract or dried plants suspended in an organic medium, and is characterized in that it contains from 1.0 to 20.0 wt. alcoholic water extract or dried stinkhorn fungus (Phallus impudicus), and contains PI-2 glucomannan as active substances. The formulation is characterized in that it contains lanolin in an amount of 40.0% to 49.5% by weight as the organic vehicle. and petroleum jelly in an amount from 40.0% to 49.5% by weight.

PL428221A 2018-12-17 2018-12-17 Preparation for use in the treatment of wounds PL242835B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL428221A PL242835B1 (en) 2018-12-17 2018-12-17 Preparation for use in the treatment of wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL428221A PL242835B1 (en) 2018-12-17 2018-12-17 Preparation for use in the treatment of wounds

Publications (2)

Publication Number Publication Date
PL428221A1 true PL428221A1 (en) 2020-06-29
PL242835B1 PL242835B1 (en) 2023-05-02

Family

ID=71124888

Family Applications (1)

Application Number Title Priority Date Filing Date
PL428221A PL242835B1 (en) 2018-12-17 2018-12-17 Preparation for use in the treatment of wounds

Country Status (1)

Country Link
PL (1) PL242835B1 (en)

Also Published As

Publication number Publication date
PL242835B1 (en) 2023-05-02

Similar Documents

Publication Publication Date Title
CO2019004137A2 (en) 1,2,4-triazolones 2,4,5-trisubstituted
BR112019000130A2 (en) agricultural formulation, aqueous formulation comprising it, agricultural treatment agent, plant product, method of treating an agricultural target and method for reducing the transmission of a plant fungal disease
MX2016003268A (en) Isolated strain of clonostachys rosea for use as a biological control agent.
WO2015112793A3 (en) Methods of expanding ex vivo natural killer t (nkt) cells and therapeutic uses thereof
WO2016116403A8 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
BR112017009980A2 (en) "system and method for prevention of alopecia".
FI20095606A7 (en) System and method for producing a solution with low suspended solids content and use of such a solution
MX367321B (en) Skin care composition and method thereof.
WO2018081183A3 (en) Maca compositions and methods of use
BR112016014578A2 (en) xyloglucan gels in fgf-18 formulation
BR112017014016A2 (en) intraocular pressure reduction method; and, pharmaceutical composition.
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
MX2023009676A (en) Betulin-containing birch bark extracts and their formulation.
BR112022001582A2 (en) Aqueous fabric spray composition, method of imparting perfume to fabric, and use of the spray composition
WO2016036324A3 (en) Novel plant functional activated nano vacc-fertiliceutical, and methods of preparation, formulation, dilution, and use thereof
PL428221A1 (en) Preparation accelerating wound healing process
BR112018069842A2 (en) agricultural co-formulation, and method of preparing co-formulation.
EA201991530A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF BIOFILMS
BR112022003639A8 (en) BIO-STIMULATING AGENT FOR TREATMENT OF PLANTS AND/OR PLANT SEEDS
BR112017000459A2 (en) methods to repel birds from a place
MX2017006657A (en) Method for the prevention and treatment of acne.
BR112018011455A2 (en) formulation of concentrated agricultural solution, and method for regulating plant growth.
EA202091062A1 (en) CARBOXYLCHITOSAN
WO2014137231A3 (en) Totarol extract formulations and uses thereof
PL422140A1 (en) Application of totarol and the totarol-containing pharmaceutical composition